Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing
Paolo Gaibani(University of Verona), Simone Ambretti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 117
Related Papers
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy
|Clinical Microbiology and Infection|2018|60
Development of a Risk Prediction Model for Carbapenem-resistant<i>Enterobacteriaceae</i>Infection After Liver Transplantation: A Multinational Cohort Study
|Clinical Infectious Diseases|2021|46
Increased <i>bla</i> <sub>KPC</sub> Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate
|Antimicrobial Agents and Chemotherapy|2022|44
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol
|Current Issues in Molecular Biology|2024|27
Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species
|European Journal of Clinical Microbiology & Infectious Diseases|2024|25